Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
Clinical trial NCT03630926 · UNKNOWN
Trial details
- NCT number
- NCT03630926
- Sponsor
- Intermountain Health Care, Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-16
- Primary completion
- 2019-08-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.